- Sponsored Content
- Downstream Processing
Separation of Monoclonal Antibody (mAb) Monomer from its Half-body using Size Exclusion Chromatography
BPI Contributor
December 1, 2013
1 Min Read
Already have an account?
Sponsored by Tosoh Bioscience
Recent research has shown an interest in mAb half-bodies as therapeutic vectors as they can be further targeted for conjugation, enzyme labeling, or antibody immobilization. The TSKgel SuperSW mAb HR is able to achieve high resolution between the mAb monomer, the mAb half-body, and fragments due to its unique pore-controlled technology optimized for mAb analysis, as well as its smaller 4 μm particle size.
About the Author
You May Also Like